CA-ZYNGA
8.3.2021 15:02:14 CET | Business Wire | Press release
Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced that it has teamed up with Girls Who Code in support of International Women’s Day 2021. With a mission to raise awareness and support for women in tech, Zynga has pledged $100,000 from its Social Impact Fund to enable Girls Who Code (GWC) to support girls at all points throughout their educational journey from 3rd grade into the workforce.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210308005082/en/
GWC is an international non-profit organization dedicated to closing the gender gap in technology. The organization has reached more than 300,000 girls in the US, Canada, UK, and India; 50 percent of girls served are Black, Latinx, or from low-income backgrounds. Through its free Clubs program, GWC reaches young women at the most critical point in the pipeline, equipping them to use Computer Science to impact their community and providing a sisterhood of supportive peers and mentors to help them persist and succeed.
“Zynga is honored to team up with Girls Who Code to help forge a more inclusive industry in tech and games by expanding opportunities for girls and women across the globe,” said Phuong Phillips, Chief Legal Officer at Zynga. “Through their virtual workshops, school clubs, mentorship programs, networking and more, we are hoping to build the next generation of women in STEAM to help them to prepare and thrive in the tech workforce. With an incredible group of women at Zynga already doing so much to support our studios and employees around the world, it’s important that we take positive steps to help strengthen the future of our industry for years to come.”
“We know that passionate, diverse, ambitious young women are the key to transforming our workplace and our world,” said Dr. Tarika Barrett, incoming CEO at Girls Who Code. “We’re excited to partner with Zynga this International Women’s Day to send a loud signal to young women everywhere that they belong in technology and that they have support in their journey from school into the workforce. Zynga and Girls Who Code share a vision of a more fair and equitable workforce, where women of all backgrounds rise to the top.”
GWC now has more than 80,000 college-aged alumni, who are majoring in Computer Science and related fields at 15 times the U.S. average. At its current pace, the organization is on track to close the gender gap in new entry-level Computer Science and related jobs by 2030. With Zynga’s support, GWC will continue to expand its free Clubs and alumni programming, helping young women unlock opportunities in the technical workforce and connecting young women to role models and mentors to support them on their journey in tech.
This March, Zynga’s social channels will be shining a spotlight on some of the incredible women who help to promote a more inclusive workplace for Zynga’s family of studios around the world. Furthermore Small Giant Games , a subsidiary of Zynga Inc., will be calling on its global network of players in Empires & Puzzles to help raise awareness by changing their alliance description to include the hashtag #ChooseToChallenge - the theme for this year’s International Women’s Day. From now until March 14, a raised hand emoji has been included exclusively for the in-game chat function and, additionally, a raised hand avatar pin will also be rewarded to players who participate in this event.
For more information please visit:
www.zynga.com
www.girlswhocode.com
www.internationalwomensday.com
Editor’s notes
Key art and assets available for use at the following link:
https://www.dropbox.com/sh/x7ey7f7kht5zbym/AADtJroaLak7G56DjgAbIVBra?dl=0
Empires & Puzzles is available to download for free on iOS and Android .
About Zynga
Zynga is a global leader in interactive entertainment with a mission to connect the world through games. To date, more than one billion people have played Zynga’s franchises including CSR Racing™
, Empires & Puzzles™
, Merge Dragons!™
, Merge Magic!™
, Toon Blast™
, Toy Blast™
, Words With Friends™
and Zynga Poker™
. Zynga’s games are available in more than 150 countries and are playable across social platforms and mobile devices worldwide. Founded in 2007, the company is headquartered in San Francisco with locations in the U.S., Canada, the U.K., Ireland, India, Turkey and Finland. For more information, visit www.zynga.com
or follow Zynga on Twitter
, Instagram
, Facebook
or the Zynga blog
.
About Girls Who Code
Girls Who Code is an international non-profit organisation working to close the gender gap in technology and change the image of what a programmer looks like and does. With their programs, they are leading the movement to inspire, educate, and equip young women with the computing skills to pursue 21st-century opportunities. Girls Who Code has reached 300,000 girls to date through its programs and 500 million people through campaigns, advocacy work, and New York Times best-selling series. To join the movement or learn more, visit girlswhocode.com. Follow the organization on social media @GirlsWhoCode.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005082/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
